Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes

Oncotarget

Volumn 5, Issue 13, 2014, Pages 4788-4798

  Bavarva, Jasmin H ^a   Tae, Hongseok ^a   McIver, Lauren ^a   Garner, Harold R ^a  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

Biomarker; Exome sequencing; MUC4; Mutation targets; Nicotine

Indexed keywords

MUCIN 4; MUCIN 6; NICOTINE; CARCINOGEN; HYDROGEN PEROXIDE; MICROSATELLITE DNA; MUC12 PROTEIN, HUMAN; MUC2 PROTEIN, HUMAN; MUC4 PROTEIN, HUMAN; MUCIN; MUCIN 2; OXIDIZING AGENT;

ARTICLE; CONTROLLED STUDY; EXOME; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INDEL MUTATION; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MICROSATELLITE MARKER; MUC12 GENE; MUC4 GENE; MUC6 GENE; OXIDATIVE STRESS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SOMATIC MUTATION; TUMOR GENE; ADENOCARCINOMA; CELL LINE; DNA SEQUENCE; DRUG EFFECTS; GENETICS; LUNG TUMOR; MUTATION; NEOPLASM; NON SMALL CELL LUNG CANCER; NUCLEOTIDE SEQUENCE; PROCEDURES; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; BASE SEQUENCE; CARCINOGENS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE; EXOME; HUMANS; HYDROGEN PEROXIDE; INDEL MUTATION; LUNG NEOPLASMS; MICROSATELLITE REPEATS; MUCIN-2; MUCIN-4; MUCINS; MUTATION; NEOPLASMS; NICOTINE; OXIDANTS; OXIDATIVE STRESS; SEQUENCE ANALYSIS, DNA; SMOKING;

EID: 84905021026     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2033     Document Type: Article

References (48)

1. Soffritti M, Belpoggi F, Esposti DD, Falcioni L and Bua L. Consequences of exposure to carcinogens beginning during developmental life. Basic & clinical pharmacology & toxicology. 2008; 102(2):118-124.
2. Belpomme D, Irigaray P, Sasco AJ, Newby JA, Howard V, Clapp R and Hardell L. The growing incidence of cancer: role of lifestyle and screening detection (Review). International journal of oncology. 2007; 30(5):1037-1049.
3. Irigaray P, Newby JA, Clapp R, Hardell L, Howard V, Montagnier L, Epstein S and Belpomme D. Lifestyle-related factors and environmental agents causing cancer: an overview. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2007; 61(10):640-658.
4. Stampfli MR and Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nature reviews Immunology. 2009; 9(5):377-384.
5. Syed BA and Chaudhari K. Smoking cessation drugs market. Nature reviews Drug discovery. 2013; 12(2):97-98.
6. Zhang S, Day IN and Ye S. Microarray analysis of nicotine-induced changes in gene expression in endothelial cells. Physiological genomics. 2001; 5(4):187-192.
7. Dunckley T and Lukas RJ. Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells. Brain research. 2006; 1116(1):39-49.
8. Karin M. NF-κB as a critical link between inflammation and cancer. Cold Spring Harbor perspectives in biology. 2009; 1(5).
9. Kalra R, Singh SP, Pena-Philippides JC, Langley RJ, Razani-Boroujerdi S and Sopori ML. Immunosuppressive and anti-inflammatory effects of nicotine administered by patch in an animal model. Clinical and diagnostic laboratory immunology. 2004; 11(3):563-568.
10. Attia SM. The genotoxic and cytotoxic effects of nicotine in the mouse bone marrow. Mutation research. 2007; 632(1-2):29-36.
11. Doolittle DJ, Winegar R, Lee CK, Caldwell WS, Hayes AW and de Bethizy JD. The genotoxic potential of nicotine and its major metabolites. Mutation research. 1995; 344(3-4):95-102.
12. Bavarva JH, Tae H, Settlage RE and Garner HR. Characterizing the Genetic Basis for Nicotine Induced Cancer Development: A Transcriptome Sequencing Study. PloS one. 2013; 8(6):e67252.
13. Genomes Project C, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME and McVean GA. A map of human genome variation from population-scale sequencing. Nature. 2010; 467(7319):1061-1073.
14. Russell MA, Jarvis M, Iyer R and Feyerabend C. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. British medical journal. 1980; 280(6219):972-976.
15. Benowitz NL, Zevin S and Jacob P, 3rd. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. British journal of clinical pharmacology. 1997; 43(3):259-267.
16. Datapharm. (2013). NiQuitin 21 mg transdermal patches. The electronic medicines compendium (eMC). (United Kingdom: Datapharm).
17. Paraytec. (2011). Application Note AN011: Real-time measurement of nicotine release from dermal patch. (United Kingdom: Paraytec Limited).
18. Basmadjian D. (2003). Mass Transfer: Principles and Applications. (Florida, USA: CRC Press LLC).
19. Kuersten S and Goodwin EB. The power of the 3' UTR: translational control and development. Nature reviews Genetics. 2003; 4(8):626-637.
20. Mascarenhas CD, Ferreira da Cunha A, Brugnerotto AF, Gambero S, de Almeida MH, Carazzolle MF, Pagnano KB, Traina F, Costa FF and de Souza CA. Identification of Target Genes Using Gene Expression Profile of Granulocytes From Chronic Myeloid Leukemia (Cml) Patients Treated With Tyrosine Kinase Inhibitors. Leukemia & lymphoma. 2013.
21. Mikaelsson E, Osterborg A, Jeddi-Tehrani M, Kokhaei P, Ostadkarampour M, Hadavi R, Gholamin M, Akhondi M, Shokri F, Rabbani H and Mellstedt H. A proline/arginine-rich end leucine-rich repeat protein (PRELP) variant is uniquely expressed in chronic lymphocytic leukemia cells. PloS one. 2013; 8(6):e67601.
22. Hollingsworth MA and Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nature reviews Cancer. 2004; 4(1):45-60.
23. Bavarva JH, McMahon W, Bavarva MJ, Karunasena E and Garner HR. Standardizing next-generation sequencing experiments and analysis methods. Clinical chemistry. 2012; 58(12):1720-1722.
24. Li YC, Korol AB, Fahima T and Nevo E. Microsatellites within genes: structure, function, and evolution. Molecular biology and evolution. 2004; 21(6):991-1007.
25. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, et al. Initial sequencing and analysis of the human genome. Nature. 2001; 409(6822):860-921.
26. Barr J, Sharma CS, Sarkar S, Wise K, Dong L, Periyakaruppan A and Ramesh GT. Nicotine induces oxidative stress and activates nuclear transcription factor kappa B in rat mesencephalic cells. Molecular and cellular biochemistry. 2007; 297(1-2):93-99.
27. Kryston TB, Georgiev AB, Pissis P and Georgakilas AG. Role of oxidative stress and DNA damage in human carcinogenesis. Mutation research. 2011; 711(1-2):193-201.
28. Lee CH, Huang CS, Chen CS, Tu SH, Wang YJ, Chang YJ, Tam KW, Wei PL, Cheng TC, Chu JS, Chen LC, Wu CH and Ho YS. Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells. Journal of the National Cancer Institute. 2010; 102(17):1322-1335.
29. Chowdhury P and Udupa KB. Nicotine as a mitogenic stimulus for pancreatic acinar cell proliferation. World journal of gastroenterology: WJG. 2006; 12(46):7428-7432.
30. Singh AP, Chaturvedi P and Batra SK. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Cancer research. 2007; 67(2):433-436.
31. Singh AP, Moniaux N, Chauhan SC, Meza JL and Batra SK. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer research. 2004; 64(2):622-630.
32. Carlsson J, Nordgren H, Sjostrom J, Wester K, Villman K, Bengtsson NO, Ostenstad B, Lundqvist H and Blomqvist C. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. British journal of cancer. 2004; 90(12):2344-2348.
33. Wirgin I, Roy NK, Loftus M, Chambers RC, Franks DG and Hahn ME. Mechanistic basis of resistance to PCBs in Atlantic tomcod from the Hudson River. Science. 2011; 331(6022):1322-1325.
34. Cohen S. Strong positive selection and habitat-specific amino acid substitution patterns in MHC from an estuarine fish under intense pollution stress. Molecular biology and evolution. 2002; 19(11):1870-1880.
35. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2012. CA: a cancer journal for clinicians. 2012; 62(1):10-29.
36. Hecht SS. Tobacco smoke carcinogens and lung cancer. Journal of the National Cancer Institute. 1999; 91(14):1194-1210.
37. Project TCLCG and Network Genomic Medicine A Genomics-Based Classification of Human Lung Tumors. Science Translational Medicine. 2013; 5(209):209ra153.
38. Galindo CL, McIver LJ, Tae H, McCormick JF, Skinner MA, Hoeschele I, Lewis CM, Minna JD, Boothman DA and Garner HR. Sporadic breast cancer patients' germline DNA exhibit an AT-rich microsatellite signature. Genes, chromosomes & cancer. 2011; 50(4):275-283.
39. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nature genetics. 2011; 43(5):491-498.
40. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M and DePristo MA. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome research. 2010; 20(9):1297-1303.
41. Jiang YH, Yuen RK, Jin X, Wang M, Chen N, Wu X, Ju J, Mei J, Shi Y, He M, Wang G, Liang J, Wang Z, Cao D, Carter MT, Chrysler C, et al. Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing. American journal of human genetics. 2013.
42. McIver LJ, Fondon JW, 3rd, Skinner MA and Garner HR. Evaluation of microsatellite variation in the 1000 Genomes Project pilot studies is indicative of the quality and utility of the raw data and alignments. Genomics. 2011; 97(4):193-199.
43. McIver LJ, McCormick JF, Martin A, Fondon JW, 3rd and Garner HR. Population-scale analysis of human microsatellites reveals novel sources of exonic variation. Gene. 2013; 516(2):328-334.
44. Wang K, Li M and Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic acids research. 2010; 38(16):e164.
45. Liu X, Jian X and Boerwinkle E. dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions. Human mutation. 2011; 32(8):894-899.
46. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, Teague JW, Campbell PJ, Stratton MR and Futreal PA. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic acids research. 2011; 39(Database issue):D945-950.
47. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, Diemer K, Muruganujan A and Narechania A. PANTHER: a library of protein families and subfamilies indexed by function. Genome research. 2003; 13(9):2129-2141.
48. Zhang H, Meltzer P and Davis S. RCircos: an R package for Circos 2D track plots. BMC bioinformatics. 2013; 14(1):244.